Amany A. Azouz - Concepedia

Author

Amany A. Azouz

Beni-Suef University ORCID

Also Known As

Amany A Azouz, Amany A. Azouz, Amany Azouz, amany azouz

Publications

797

Citations

H-Index

Concepts

All Affiliations

Beni-Suef University Al-Azhar University Jouf University Cairo University Egyptian Russian University

About

Amany A. Azouz is an author at Beni-Suef University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	535
2	Biochemistry	5	5	276
3	Natural Sciences	4	4	187
4	Health Sciences	1	1	11
5	Cell Biology	1	1	28

Amany A. Azouz

Publications

766

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies Mohamed A. Abdelgawad, Madlen B. Labib, Waleed A.M. Ali, Bioorganic Chemistry Anti-inflammatoryBiochemistryCox-2/5-lox EnzymesMedicineNovel Pyrazolones	2018	89
Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability Mohamed A. Abdelgawad, Rania B. Bakr, Amany A. Azouz Bioorganic Chemistry Medicinal ChemistryCyclooxygenase InhibitionBiochemistryNatural SciencesMedicine	2018	81
Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study Phoebe F. Lamie, John N. Philoppes, Amany A. Azouz, Journal of Enzyme Inhibition and Medicinal Chemistry	2017	68
Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis Fares E.M. Ali, Adel G. Bakr, Amira M. Abo‐Youssef, Life Sciences InflammationPotential Protective MechanismHepatologyMedicineLiver Physiology	2018	62
Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway Fares E.M. Ali, Amany A. Azouz, Adel G. Bakr, Food and Chemical Toxicology InflammationHepatologyMedicineLiver PhysiologyPathology	2018	61
Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC Heba A.H. Elshemy, Eman K. A. Abdelall, Amany A. Azouz, European Journal of Medicinal Chemistry Medicinal ChemistryPoly-substituted 1,3,5-TriazinesHeterocyclicBiochemistryMedicine	2016	57
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-<i>d</i>]pyrimidine derivatives Rania B. Bakr, Amany A. Azouz, Khaled R.A. Abdellatif Journal of Enzyme Inhibition and Medicinal Chemistry	2016	49
Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold Rania B. Bakr, Amira A. Ghoneim, Amany A. Azouz Bioorganic Chemistry Medicinal ChemistryAnti-inflammatoryAnti-inflammatory AgentsBiochemistryMedicine	2019	36
Discovery of a Cox-2 Selective Inhibitor Hit with Anti-Inflammatory Activity and Gastric Ulcer Protective Effect Mohamed A. Abdelgawad, Rania B. Bakr, Ahmed O. El‐Gendy, Future Medicinal Chemistry	2017	28
Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression Esraa Abdel-Nassir Abdel-Razek, Amira M. Abo‐Youssef, Amany A. Azouz Life Sciences Redox SignalingMolecular PharmacologyPeroxisome Proliferator-activated Receptor-alphaMedicineLipid Peroxidation	2020	28

Page 1